Chromosomal rearrangements that fuse NH2-terminal sequences of the Bcr protein to COOH-terminal sequences of the Abl tyrosine kinase (Bcr-Abl) are associated with virtually all cases of chronic myelogenous leukemia (CML). In preliminary studies we have identified and verified an interaction between Bcr and the TSG101 tumor suppressor protein. TSG101 is a component of the ESCRT1 complex which recognizes and partitions endosomal cargo into the multivesicular body. The association with TSG101 suggests that Bcr may also be a component of the endosomal trafficking machinery. Since defects in endosomal trafficking have been described in the context of transformation, disruption of the Bcr-TSG101 association may be relevant to CML.
The aim of this proposal is to determine whether Bcr is a bona fide regulator of endosomal trafficking, and to determine whether this process is disrupted in the context of Bcr-Abl transformed cells. Additionally, we will examine the possibility that Bcr regulates the steady-state levels of TSG101. Using a combination of GST-based in vitro binding assays, and indirect immunofluorescence, we will determine whether Bcr physically localizes with the endosomal sorting machinery. To examine the functional consequences of this interaction, we will suppress Bcr expression by siRNAs and determine whether endosomal sorting is disrupted in HeLa cells, as well as in Bcr-Abl positive cells. Finally, we will determine if TSG101 steady state levels are sensitive to Bcr dosage, and whether this effect is mediated by ubiquitination. If the interaction between Bcr and TSG101 is physiologically relevant, these studies may uncover a mitigating factor in Bcr-Abl-mediated transformationthat was not previously appreciated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31CA117049-02
Application #
7152519
Study Section
Special Emphasis Panel (ZRG1-IDM-P (29))
Program Officer
Bini, Alessandra M
Project Start
2005-12-01
Project End
2008-11-30
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
2
Fiscal Year
2007
Total Cost
$26,179
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
623946217
City
Newark
State
NJ
Country
United States
Zip Code
07107
Rodriguez, Pedro L; Sahay, Sutapa; Olabisi, Oyenike O et al. (2007) ROCK I-mediated activation of NF-kappaB by RhoB. Cell Signal 19:2361-9
Kostenko, Elena V; Olabisi, Oyenike O; Sahay, Sutapa et al. (2006) Ccpg1, a novel scaffold protein that regulates the activity of the Rho guanine nucleotide exchange factor Dbs. Mol Cell Biol 26:8964-75
Olabisi, Oyenike O; Mahon, Gwendolyn M; Kostenko, Elena V et al. (2006) Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover. Cancer Res 66:6250-7